Form 8-K MBX Biosciences, Inc. For: Jan 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
MBX Biosciences to present pipeline updates at JP Morgan conference
January 12, 2026 6:05 AM ESTMBX Biosciences Inc. (NASDAQ: MBX) announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026, at 3:45 pm PT. The clinical-stage biopharmaceutical company will provide updates on its clinical programs, obesity pipeline, and 2026 outlook during the presentation.
The company reported that its Phase... More
